RxDoctor Payments Data

Brandi Wilson, NP

Family · Marshall, NCNPI 1164057857

Payments from drug & device makers

$666in general payments, 2019–2025

Across 34 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$294
  • Lilly USA, LLC$85
  • AbbVie$73
  • Bayer$54
  • Otsuka America Pharmaceutical, Inc.$28
  • Sanofi Pasteur Inc.$23
  • plus $110 from 7 others

What the payments were for

  • Food & beverage$666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 60th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$414
Medicare patients
26
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$49,580
JardianceEmpagliflozin40$41,108
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$22,657
MounjaroTirzepatide20$20,342
EliquisApixaban18$13,806
Tresiba Flextouch U-100Insulin Degludec15$13,744
TrulicityDulaglutide14$12,831
EntrestoSacubitril/Valsartan11$11,260
Advair HfaFluticasone Propion/Salmeterol28$8,865
Praluent PenAlirocumab13$6,703
Gabapentin81$1,623
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,511
Omeprazole98$1,304
Bupropion XlBupropion Hcl28$1,287
Albuterol Sulfate HfaAlbuterol Sulfate48$1,190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$294$49,58050 claims
Lilly USA, LLCMounjaro, Trulicity$85$33,17334 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,522 family providers in North Carolina.

Other family in Marshall

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →